tiprankstipranks
Trending News
More News >
Hold Rating for Nurix Therapeutics Amid Competitive Challenges and Strategic Uncertainties
PremiumRatingsHold Rating for Nurix Therapeutics Amid Competitive Challenges and Strategic Uncertainties
17d ago
Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer
Premium
The Fly
Nurix Therapeutics price target lowered to $32 from $35 at Oppenheimer
18d ago
Nurix Therapeutics price target lowered to $25 from $32 at Wells Fargo
Premium
The Fly
Nurix Therapeutics price target lowered to $25 from $32 at Wells Fargo
18d ago
Nurix Therapeutics Q1 2025 Financial Highlights
PremiumCompany AnnouncementsNurix Therapeutics Q1 2025 Financial Highlights
18d ago
Nurix Therapeutics reports Q1 EPS (67c), consensus (76c)
Premium
The Fly
Nurix Therapeutics reports Q1 EPS (67c), consensus (76c)
19d ago
NRIX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
NRIX Earnings this Week: How Will it Perform?
20d ago
Nurix Therapeutics treatment of Waldenstrom macroglobulinemia gets orphan status
PremiumThe FlyNurix Therapeutics treatment of Waldenstrom macroglobulinemia gets orphan status
1M ago
Nurix Therapeutics Appoints Dr. Roy D. Baynes to Board
Premium
Company Announcements
Nurix Therapeutics Appoints Dr. Roy D. Baynes to Board
1M ago
Nurix Therapeutics price target raised to $17 from $16 at Morgan Stanley
Premium
The Fly
Nurix Therapeutics price target raised to $17 from $16 at Morgan Stanley
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100